Treatment of hepatitis C: Results in real life

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|38|S1|21-27

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.38, Iss.S1, 2018-02, pp. : 21-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 3, 2018-02 ,pp. : 421-431

John Wiley & Sons Inc

Access to resources Recommend Favorite

P147: A phenotypic NS3‐protease inhibitor resistance assay to characterize resistance‐associated mutations in patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 93-93

John Wiley & Sons Inc

Access to resources Recommend Favorite

P004: The distribution and dynamic changes of serum 25(OH)D3 in Chinese chronic hepatitis B patients with nucleoside analogue treatment: results from a real‐life setting study

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 21-21

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis C Treatment of Opioid Dependants Receiving Maintenance Treatment: Results of a Norwegian Pilot Study

By  

European Addiction Research, Vol. 13, Iss. 4, 2007-09 ,pp. : 216-221

Karger

Access to resources Recommend Favorite

P152: Real‐world effectiveness of Ledipasvir/Sofosbuvir 8 weeks chronic hepatitis C treatment

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 95-96

John Wiley & Sons Inc

Access to resources Recommend Favorite